Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients with Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy https://kusajili.com:443/Trial/CTmxJaJf3keMS-Vm663KeA%24a-multicenter-randomized-double-blind-parallel-group-placebo-controlled-phase-iii-efficacy-and-safety-study-of-3-fixed-dose-gro
I have read and accept the terms of use of the site and the Privacy Policy
Send your message